genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Financing
Benchtop Genome Engineering Platform Developer Inscripta Raises $125M in Series D…
News
Human Genes 10% More Numerous, If You Count smORFs
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Extracellular Matrix
Mapping Single-Cell pH Levels Could Hold Key to Improved Cancer Treatments
Insights
Bioprocessing
Insect Pupae May Transform Protein Production
Bioprocessing
Optimizing Biotherapeutic Onboarding
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
A-Lists
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Financing
Benchtop Genome Engineering Platform Developer Inscripta Raises $125M in Series D…
News
Human Genes 10% More Numerous, If You Count smORFs
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Magazine
All
Supplement
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
December 2019 Vol. 39 No. 12
Taking Cell Lines to the Bank
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Dynamic Microbiome
December 2019 Vol. 39 No. 12
Understanding and Overcoming the Immune Response from Synthetic mRNAs
December 2019 Vol. 39 No. 12
Accelerating AAV to the Clinic with Purification Improvements
December 2019 Vol. 39 No. 12
Evaluation of a Small-Scale Perfusion Mimic for Intensified Processes
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Hematologic Conditions
Hematologic Conditions
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Hematologic Conditions
Chimerix Licenses Cantex’s CX-01 for AML after Promising Phase II Results
Hematologic Conditions
After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045
Hematologic Conditions
AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals
Hematologic Conditions
Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167
Hematologic Conditions
Reversible Technique Developed for Stem Cell Expansion
Hematologic Conditions
Curcumin Shown to Inhibit DYRK2 and Reduce Cancer Burden
Hematologic Conditions
CRISPR Improves Red Blood Cell Transfusion Success
Hematologic Conditions
Model Wound System Created that Self Heals
Hematologic Conditions
Shire Hemophilia Candidate Using Xenetic Platform Falls Short in Trial
Hematologic Conditions
Nohla and UC Davis Ink Manufacturing Deal for Off-the-Shelf Donor Stem...
Hematologic Conditions
Novartis Acquires Selexys Pharmaceuticals
Hematologic Conditions
Takeda to Co-Develop Gencia’s MAGR Drugs in Up-to-$500M+ Partnership
Hematologic Conditions
Blood-Cleansing Biospleen Developed
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Synthetic biologists at the University of Bristol have succeeded in generating laboratory-made red blood cells with rare blood group types. [Dr. Ashley Toye/University of Bristol]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr30_2018_UnivBristol_GeneEditedRedBloodCells1901781571-324x160.jpg "CRISPR Improves Red Blood Cell Transfusion Success")
